1.
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS)...
by Forbes, John F, Prof
The Lancet (British edition), 2015, Vol.387 (10021), p.866-873
2.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
by Cuzick, Jack, Prof
The Lancet (British edition), 2014, Vol.383 (9922), p.1041-1048
3.
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
by Cuzick, Jack, Prof
The Lancet (British edition), 2013, Vol.381 (9880), p.1827-1834
4.
E-cadherin germline mutations in Māori population
by De Scalzi, Alessandra Margherita
Future oncology (London, England), 2019-04-01, Vol.15 (12), p.1291-1294
5.
Prognostic impact of germline mutations in inherited cancer syndromes
by Corso, Giovanni
Future oncology (London, England), 2017-10-01, Vol.13 (24), p.2125-2127
6.
Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer?
by Garcia-Etienne, Carlos A
Annals of surgical oncology, 2009-08-01, Vol.16 (12), p.3380-3387
7.
Synthetic retinoid fenretinide in breast cancer chemoprevention
by Bonanni, Bernardo
Expert review of anticancer therapy, 2007-04-01, Vol.7 (4), p.423-432
8.
Male breast cancer
by Zurrida, Stefano
Future oncology (London, England), 2010-06-01, Vol.6 (6), p.985-991
9.
Breast Cancer Chemoprevention: Old and New Approaches
by Cazzaniga, Massimiliano
Journal of biomedicine & biotechnology, 2012-07-09, Vol.2012, p.985620-15
10.
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
by Mavaddat, Nasim Nasim
American journal of human genetics, 2018-12-13, Vol.104 (1), p.21-34
11.
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women
by BONANNI, Bernardo
Breast cancer research and treatment, 2001, Vol.69 (1), p.21-27
12.
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
by Ghoussaini, Maya
American journal of human genetics, 2013-04-04, Vol.92 (4), p.489-503
13.
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
by Meyer, Kerstin B
American journal of human genetics, 2013-12-05, Vol.93 (6), p.1046-1060
14.
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo
by Catucci, Irene
Genetics in medicine, 2014-09, Vol.16 (9), p.688-694
15.
Does tamoxifen prophylaxis for breast cancer provide long-term prevention?
by Veronesi, Umberto
Nature clinical practice. Oncology, 2007-10, Vol.4 (10), p.568-569
16.
Fenretinide and risk reduction of second breast cancer
by Decensi, Andrea
Nature clinical practice. Oncology, 2007-02, Vol.4 (2), p.64-65
